A Phase I, open-label trial to investigate pharmacokinetics, safety and tolerability of TMC125 at steady-state in treatment-experienced HIV-1 infected children.
Phase of Trial: Phase I
Latest Information Update: 29 Aug 2011
At a glance
- Drugs Etravirine (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 29 Aug 2011 New trial record